Rituximab in the treatment of non-Hodgkin's lymphoma.
Besides traditional cytostatic drugs the introduction of monoclonal antibodies has substantially influenced current treatment concepts of non-Hodgkin's lymphoma (NHL). Rituximab, a monoclonal anti-CD20 chimeric antibody, now has been widely evaluated in the various B-cell lymphatic neoplasms. Large phase III studies helped to prove the value of this drug in follicular lymphoma as part of induction or relapse treatment as well as maintenance treatment. The addition of rituximab to the well established CHOP regimens has increased achievable cure rates in diffuse large cell lymphoma, and this combination is now accepted worldwide as standard of care. Although conflicting results are available, rituximab is widely used for the treatment of mantle cell lymphoma. For the less frequent lymphoma entities phase 2 studies show a considerable efficiency for most of these B-NHL variants. Current research focuses on combined chemoimmunotherapy approaches, optimization of dosing regimens, and combination with novel agents.
Hauptrock
Beate
B
Hematology/Oncology, Johannes Gutenberg-University, Mainz, Germany.
Hess
Georg
G
Blood. 2005 Dec 1;106(12):3725-32
16123223
Clin Cancer Res. 2004 Dec 15;10(24):8620-9
15623646
Blood. 1994 Sep 1;84(5):1361-92
8068936
Blood. 2007 Jan 15;109(2):405-11
17008537
Nat Med. 2000 Apr;6(4):443-6
10742152
Nature. 1975 Aug 7;256(5517):495-7
1172191
Ann Oncol. 2005 Jan;16(1):132-8
15598950
Blood. 1998 Sep 15;92(6):1927-32
9731049
Blood. 1994 Oct 15;84(8):2457-66
7522629
J Clin Oncol. 2003 Aug 15;21(16):3051-9
12837807
Jpn J Clin Oncol. 2008 May;38(5):373-80
18413337
Semin Oncol. 2003 Apr;30(2):110-5
12720118
Lancet. 1991 Nov 9;338(8776):1175-6
1682595
Leuk Res. 2005 Jan;29(1):107-8
15541482
J Clin Oncol. 2005 Oct 1;23(28):7013-23
16145068
J Clin Oncol. 2007 Apr 10;25(11):1350-6
17312328
Blood. 2006 Nov 15;108(10):3295-301
16873669
Blood. 1996 Mar 1;87(5):1972-6
8634446
J Clin Oncol. 2004 Dec 1;22(23):4711-6
15483015
Leukemia. 1995 Jul;9(7):1116-20
7630181
N Engl J Med. 1987 Apr 2;316(14):825-30
2434850
Eur J Haematol. 2004 Oct;73(4):258-62
15347312
J Clin Oncol. 2001 Apr 15;19(8):2153-64
11304767
J Clin Oncol. 1995 Apr;13(4):974-82
7707126
Hematol J. 2004;5(6):467-71
15570286
J Immunother. 2001 May-Jun;24(3):272-9
11394506
Ann Hematol. 2007 Aug;86(8):599-607
17522862
J Clin Oncol. 2008 Jul 1;26(19):3166-75
18490650
J Clin Oncol. 2004 Nov 15;22(22):4561-6
15542807
Cancer Res. 1980 Sep;40(9):3147-54
7427932
J Clin Oncol. 2000 Sep;18(17):3135-43
10963642
Blood. 2006 Dec 15;108(13):4003-8
16946304
J Clin Oncol. 2002 May 1;20(9):2327-33
11981004
J Clin Oncol. 2005 Jul 1;23(19):4390-8
15994148
J Clin Oncol. 2007 Oct 20;25(30):4730-5
17947720
J Immunol. 2000 Nov 15;165(10):5954-61
11067958
J Clin Oncol. 2005 Feb 1;23(4):705-11
15598978
Hematol Oncol. 2007 Sep;25(3):127-31
17514771
World J Gastroenterol. 2007 Jul 14;13(26):3554-66
17659705
Oncogene. 2003 Oct 20;22(47):7359-68
14576843
Blood. 2003 Jun 1;101(11):4279-84
12576316
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7151s-7157s
16203815
J Clin Oncol. 2005 May 20;23(15):3383-9
15908650
Clin Cancer Res. 2006 Jan 1;12(1):242-9
16397048
Blood. 2002 Feb 1;99(3):754-8
11806974
Leuk Lymphoma. 2004 Oct;45(10):2047-55
15370249
J Clin Oncol. 2005 Feb 20;23(6):1088-95
15657401
Haematologica. 2004 Jun;89(6):753-4
15194546
J Clin Oncol. 2005 Sep 10;23(26):6387-93
16155024
Clin Cancer Res. 2001 Aug;7(8):2195-204
11489792
Semin Oncol. 1987 Jun;14(2 Suppl 2):13-7
3589701
Blood. 2004 Mar 15;103(6):2332-6
14630803
J Clin Oncol. 2008 Jun 1;26(16):2725-31
18427151
Bone Marrow Transplant. 2002 May;29(9):769-75
12040475
Am J Hematol. 1999 Dec;62(4):247-50
10589082
J Clin Oncol. 2004 Jul 1;22(13):2654-61
15159414
Curr Opin Oncol. 2007 Sep;19(5):458-63
17762571
Blood. 2003 Aug 1;102(3):810-3
12663446
Ann Hematol. 2006 Nov;85(11):769-79
16896912
J Clin Oncol. 2008 Jun 1;26(16):2607-9
18509168
J Clin Oncol. 2006 Jul 1;24(19):3121-7
16754935
Blood. 2002 Aug 1;100(3):1104-5
12150156
Eur J Haematol. 2007 Aug;79(2):107-13
17635235
Semin Oncol. 2000 Dec;27(6 Suppl 12):17-24
11225995
Blood. 2003 Oct 15;102(8):2741-5
12842999
Leuk Lymphoma. 1994;14 Suppl 1:67-71
7820056
Leukemia. 2009 Jan;23(1):153-61
18818699
N Engl J Med. 2002 Jan 24;346(4):235-42
11807147
J Clin Oncol. 2003 May 1;21(9):1746-51
12721250
Leukemia. 2007 Apr;21(4):835-6
17268523
N Engl J Med. 1990 Apr 19;322(16):1117-21
1969613
Blood. 2000 Aug 1;96(3):864-9
10910898
J Clin Oncol. 2007 Aug 1;25(22):3344-9
17577016
Blood. 1992 Sep 15;80(6):1502-10
1520877
Clin Lymphoma. 2002 Jun;3(1):41-7
12141954
Br J Haematol. 2007 Mar;136(5):685-98
17229246
Lancet Oncol. 2006 May;7(5):379-91
16648042
N Engl J Med. 1995 Dec 7;333(23):1540-5
7477169
Ann Hematol. 2007 Feb;86(2):107-15
17103169
J Clin Oncol. 2005 Mar 20;23(9):1979-83
15668468
Blood. 2003 Aug 1;102(3):1070-1
12702507
Am J Hematol. 2006 Apr;81(4):302
16550511
Blood. 2005 Feb 15;105(4):1417-23
15494430
J Clin Oncol. 2005 Jun 20;23(18):4070-8
15767647
J Clin Oncol. 2001 Jan 15;19(2):389-97
11208830
Br J Dermatol. 2006 Nov;155(5):1053-6
17034541
Blood. 1998 Nov 1;92(9):3137-47
9787149
Blood. 2006 Apr 15;107(8):3053-7
16254143
Haematologica. 2007 Jan;92(1):42-9
17229634
Blood. 2001 Jan 1;97(1):101-6
11133748
Blood. 2002 Feb 15;99(4):1486-8
11830505
J Clin Oncol. 2005 Jun 20;23(18):4079-88
15767648
Leukemia. 2008 May;22(5):1082-3
17972949
J Clin Oncol. 2007 May 20;25(15):1986-92
17420513
Neurology. 2004 Sep 14;63(5):901-3
15365145
Cancer. 2006 Apr 1;106(7):1569-80
16502413
Blood. 2001 Sep 1;98(5):1326-31
11520778
Blood. 2000 Feb 1;95(3):1056-65
10648422
Clin Cancer Res. 2004 Aug 15;10(16):5327-34
15328168
J Clin Oncol. 2006 Sep 1;24(25):4123-8
16896005
Semin Oncol. 1999 Oct;26(5 Suppl 14):88-96
10561023
J Clin Oncol. 1998 Aug;16(8):2825-33
9704735
Blood. 1987 Feb;69(2):584-91
3492224
J Immunother. 2002 Jan-Feb;25(1):72-81
11924912
Blood. 2008 Aug 15;112(4):975-80
18411418
Clin Lab Haematol. 2006 Jun;28(3):211-4
16706940
J Clin Oncol. 2005 Mar 20;23(9):1984-92
15668467
Lancet Oncol. 2008 Feb;9(2):105-16
18226581
Br J Haematol. 1999 Aug;106(2):545-52
10460621
Expert Opin Drug Saf. 2005 May;4(3):599-608
15934864
Lancet Oncol. 2008 May;9(5):435-44
18400558
J Clin Oncol. 2001 Apr 15;19(8):2165-70
11304768
Haematologica. 2006 May;91(5):715-6
16670080
J Clin Oncol. 2003 Jun 15;21(12):2407-14
12805341
Blood. 2004 May 15;103(10):3684-8
14739217
Blood. 2006 Jun 15;107(12):4658-62
16497968
Blood. 2003 Aug 1;102(3):996-9
12714514
Blood. 2003 Dec 1;102(12):3906-11
12816862
Lancet Oncol. 2003 Feb;4(2):95-103
12573351
Blood. 2005 Sep 1;106(5):1538-43
15914552
Haematologica. 2001 Oct;86(10):1046-50
11602410
Blood. 2004 Nov 15;104(10):3064-71
15284112
Ann Hematol. 1998 Jul-Aug;77(1-2):89-91
9760161
Blood. 2004 Jun 15;103(12):4416-23
14976046